Anticoagulation results in increased line salvage for children with intestinal failure and central venous thrombosis

Cory M. McLaughlin, Monica Bennett, Nandini Channabasappa, Janna Journeycake, Hannah G. Piper

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of this study was to investigate whether anticoagulation (AC) results in thrombus resolution and increased line longevity in children with intestinal failure (IF) and catheter-associated central venous thrombosis (CVT). Methods: A retrospective, single institution review was performed of children with IF who were dependent on parenteral nutrition with known CVT between 2006 and 2017. Frequency of catheter-related complications including infection, occlusion, and breakage were compared 18. months prior to and after starting AC. Thrombus resolution during anticoagulation was also determined. Data were analyzed using Poisson regression. p-Values <. 0.05 were considered significant. Results: Eighteen children had ≥. 1 CVT, with the subclavian vein most commonly thrombosed (44%). All children were treated with low molecular weight heparin, and 6 patients (33%) had clot resolution on re-imaging while receiving AC. Bloodstream infections decreased from 7.9 to 4.4 per 1000 catheter days during AC (p = 0.01), and the number of infections requiring catheter replacement decreased from 3.0 to 1.0 per 1000 catheter days (p = 0.01). There were no significant differences in line occlusions or breakages. Conclusion: Anticoagulation for children with intestinal failure and central venous thrombosis may prevent thrombus propagation, and decrease blood stream infections and line replacements. Further research is needed to determine optimal dosing and duration of therapy. Level of Evidence: III; Retrospective Comparative Study.

Original languageEnglish (US)
JournalJournal of Pediatric Surgery
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Venous Thrombosis
Thrombosis
Catheters
Infection
Upper Extremity Deep Vein Thrombosis
Subclavian Vein
Low Molecular Weight Heparin
Parenteral Nutrition
Retrospective Studies
Research
Therapeutics

Keywords

  • Anticoagulation
  • Catheter
  • Central venous thrombosis
  • Intestinal failure
  • Short bowel syndrome
  • Thromboprophylaxis

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Anticoagulation results in increased line salvage for children with intestinal failure and central venous thrombosis. / McLaughlin, Cory M.; Bennett, Monica; Channabasappa, Nandini; Journeycake, Janna; Piper, Hannah G.

In: Journal of Pediatric Surgery, 01.01.2018.

Research output: Contribution to journalArticle

@article{d6b6cc409cfc4fce95ea935d8f49dfa3,
title = "Anticoagulation results in increased line salvage for children with intestinal failure and central venous thrombosis",
abstract = "Purpose: The purpose of this study was to investigate whether anticoagulation (AC) results in thrombus resolution and increased line longevity in children with intestinal failure (IF) and catheter-associated central venous thrombosis (CVT). Methods: A retrospective, single institution review was performed of children with IF who were dependent on parenteral nutrition with known CVT between 2006 and 2017. Frequency of catheter-related complications including infection, occlusion, and breakage were compared 18. months prior to and after starting AC. Thrombus resolution during anticoagulation was also determined. Data were analyzed using Poisson regression. p-Values <. 0.05 were considered significant. Results: Eighteen children had ≥. 1 CVT, with the subclavian vein most commonly thrombosed (44{\%}). All children were treated with low molecular weight heparin, and 6 patients (33{\%}) had clot resolution on re-imaging while receiving AC. Bloodstream infections decreased from 7.9 to 4.4 per 1000 catheter days during AC (p = 0.01), and the number of infections requiring catheter replacement decreased from 3.0 to 1.0 per 1000 catheter days (p = 0.01). There were no significant differences in line occlusions or breakages. Conclusion: Anticoagulation for children with intestinal failure and central venous thrombosis may prevent thrombus propagation, and decrease blood stream infections and line replacements. Further research is needed to determine optimal dosing and duration of therapy. Level of Evidence: III; Retrospective Comparative Study.",
keywords = "Anticoagulation, Catheter, Central venous thrombosis, Intestinal failure, Short bowel syndrome, Thromboprophylaxis",
author = "McLaughlin, {Cory M.} and Monica Bennett and Nandini Channabasappa and Janna Journeycake and Piper, {Hannah G.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jpedsurg.2018.02.007",
language = "English (US)",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Anticoagulation results in increased line salvage for children with intestinal failure and central venous thrombosis

AU - McLaughlin, Cory M.

AU - Bennett, Monica

AU - Channabasappa, Nandini

AU - Journeycake, Janna

AU - Piper, Hannah G.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: The purpose of this study was to investigate whether anticoagulation (AC) results in thrombus resolution and increased line longevity in children with intestinal failure (IF) and catheter-associated central venous thrombosis (CVT). Methods: A retrospective, single institution review was performed of children with IF who were dependent on parenteral nutrition with known CVT between 2006 and 2017. Frequency of catheter-related complications including infection, occlusion, and breakage were compared 18. months prior to and after starting AC. Thrombus resolution during anticoagulation was also determined. Data were analyzed using Poisson regression. p-Values <. 0.05 were considered significant. Results: Eighteen children had ≥. 1 CVT, with the subclavian vein most commonly thrombosed (44%). All children were treated with low molecular weight heparin, and 6 patients (33%) had clot resolution on re-imaging while receiving AC. Bloodstream infections decreased from 7.9 to 4.4 per 1000 catheter days during AC (p = 0.01), and the number of infections requiring catheter replacement decreased from 3.0 to 1.0 per 1000 catheter days (p = 0.01). There were no significant differences in line occlusions or breakages. Conclusion: Anticoagulation for children with intestinal failure and central venous thrombosis may prevent thrombus propagation, and decrease blood stream infections and line replacements. Further research is needed to determine optimal dosing and duration of therapy. Level of Evidence: III; Retrospective Comparative Study.

AB - Purpose: The purpose of this study was to investigate whether anticoagulation (AC) results in thrombus resolution and increased line longevity in children with intestinal failure (IF) and catheter-associated central venous thrombosis (CVT). Methods: A retrospective, single institution review was performed of children with IF who were dependent on parenteral nutrition with known CVT between 2006 and 2017. Frequency of catheter-related complications including infection, occlusion, and breakage were compared 18. months prior to and after starting AC. Thrombus resolution during anticoagulation was also determined. Data were analyzed using Poisson regression. p-Values <. 0.05 were considered significant. Results: Eighteen children had ≥. 1 CVT, with the subclavian vein most commonly thrombosed (44%). All children were treated with low molecular weight heparin, and 6 patients (33%) had clot resolution on re-imaging while receiving AC. Bloodstream infections decreased from 7.9 to 4.4 per 1000 catheter days during AC (p = 0.01), and the number of infections requiring catheter replacement decreased from 3.0 to 1.0 per 1000 catheter days (p = 0.01). There were no significant differences in line occlusions or breakages. Conclusion: Anticoagulation for children with intestinal failure and central venous thrombosis may prevent thrombus propagation, and decrease blood stream infections and line replacements. Further research is needed to determine optimal dosing and duration of therapy. Level of Evidence: III; Retrospective Comparative Study.

KW - Anticoagulation

KW - Catheter

KW - Central venous thrombosis

KW - Intestinal failure

KW - Short bowel syndrome

KW - Thromboprophylaxis

UR - http://www.scopus.com/inward/record.url?scp=85042467796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042467796&partnerID=8YFLogxK

U2 - 10.1016/j.jpedsurg.2018.02.007

DO - 10.1016/j.jpedsurg.2018.02.007

M3 - Article

C2 - 29499845

AN - SCOPUS:85042467796

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

ER -